Beijing Enterprises (China)

Recent papers from Beijing Enterprises (China)

1. Interfacial Instability and Induced Safety Failure Mechanisms in Sulfide Solid ElectrolytesBatteries · 2026
2. Protective effects of Hoveniae Semen Seu Fructus extract on acute alcoholic liver injury and the development of hangover beveragesJournal of Agriculture and Food Research · 2026
3. Tislelizumab plus chemotherapy for advanced or metastatic esophageal squamous-cell carcinoma in patients with PD-L1 Tumor Area Positivity score ≥5%: a post hoc, exploratory, long-term follow-up of RATIONALE-306☆ESMO Open · 2026
4. Numerical Analysis of Sand-Induced Erosion in a Transonic Axial Compressor Rotor Under Varying Particle SizesJournal of Turbomachinery · 2026
5. Integrated metabolomic and proteomic profiling reveals density-dependent variation in development and chemical composition of queen bee larvaeChemical and Biological Technologies in Agriculture · 2026
6. How does digital-intelligent policy synergy foster ambidextrous innovation of manufacturing enterprises? The mediating role of resource endowmentsEuropean Journal of Innovation Management · 2026
7. AdvanTIG-301: a phase III study of ociperlimab plus tislelizumab and concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancerJournal for ImmunoTherapy of Cancer · 2026
8. How does spatial expansion of higher education affect urban innovation? Regional evidence for Yangtze River Delta, ChinaThe Annals of Regional Science · 2026
9. Real-world treatments and outcomes in metastatic and recurrent esophageal squamous cell carcinoma in Japan: a retrospective analysis using the Millennial Medical Record databaseEsophagus · 2026
10. Adaptive Stability Control of a High-Speed Axial Flow Fan under Circumferential Distortion Inlet ConditionsJournal of Turbomachinery · 2026
11. Perioperative tislelizumab plus chemotherapy for locally advanced gastric cancer: A randomized, prospective phase 2 trialCancer Cell · 2026
12. Physics About Heat and Mass Transfer During Power Ultrasound‐Enhanced Green Food ProcessingComprehensive Reviews in Food Science and Food Safety · 2026
13. Model‐Informed Development of a Subcutaneous Formulation of Tislelizumab: Phase 1 Pharmacokinetics in Patients With CancerClinical and Translational Science · 2026
14. Integration of flow decomposition and discharge testing for customer-side leakage detection in district metered areasAQUA - Water Infrastructure Ecosystems and Society · 2026
15. A Case Study on the Impact of Thermal Hydrolysis and Lactone Ring Opening of Linker-Payload on Drug-to-Antibody Ratio Determination in a Topoisomerase I Inhibitor-Based ADCBioconjugate Chemistry · 2026
16. Understanding Economic Resilience Using New Quality Productivity Across Multi-Scale Spatial Locations: Machine-Based Spatio-Temporal EffectsLand · 2026
17. Efficacy and safety of tislelizumab as neoadjuvant therapy combined with MRD monitoring in locally advanced dMMR/MSI-H colon cancer: A prospective pilot study.Journal of Clinical Oncology · 2026
18. Characterization and management of gastrointestinal (GI) adverse events (AEs) with zanidatamab + chemotherapy (CT) ± tislelizumab in first-line (1L) HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (mGEA): Analysis from HERIZON-GEA-01.Journal of Clinical Oncology · 2026
19. Zanidatamab + chemotherapy (CT) ± tislelizumab for first-line (1L) HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (mGEA): PD-L1 subgroup analysis from HERIZON-GEA-01.Journal of Clinical Oncology · 2026
20. Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal CancerNew England Journal of Medicine · 2026